Last reviewed · How we verify
Arvinas Androgen Receptor, Inc. — Portfolio Competitive Intelligence Brief
0 marketed
0 filed
0 Phase 3
0 Phase 2
1 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
Therapeutic area mix
- Oncology · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Aragon Pharmaceuticals, Inc. · 1 shared drug class
- Astellas Pharma · 1 shared drug class
- AstraZeneca · 1 shared drug class
- City of Hope Medical Center · 1 shared drug class
- Pfizer Inc. · 1 shared drug class
- Tata Memorial Centre · 1 shared drug class
- Triple Hair Inc · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Arvinas Androgen Receptor, Inc.:
- Arvinas Androgen Receptor, Inc. pipeline updates — RSS
- Arvinas Androgen Receptor, Inc. pipeline updates — Atom
- Arvinas Androgen Receptor, Inc. pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Arvinas Androgen Receptor, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/arvinas-androgen-receptor-inc. Accessed 2026-05-17.